Findings provide an opportunity to develop drugs and vaccines for coronaviruses before they emerge from animals to cause a human epidemic
Researchers from the University of North Carolina at Chapel Hill have discovered a new bat SARS-like virus that can jump directly from its bat hosts to humans without mutation. However, researchers point out that if the SARS-like virus did jump, it is still unclear whether it could spread from human to human.
The discovery, reported in the Nov. 9 issue of Nature Medicine, is notable not only because there is no treatment for this newly discovered virus, but also because it highlights an ongoing debate over the government’s decision to suspend all gain of function experiments on a variety of select agents earlier this year. The move has put a substantial standstill on the development of vaccines or treatments for these pathogens should there be an outbreak.
“Studies have predicted the existence of nearly 5,000 coronaviruses in bat populations and some of these have the potential to emerge as human pathogens,” said senior author Ralph Baric, a faculty member at the Gillings School of Global Public Health and world-renowned expert in coronaviruses. “So this is not a situation of ‘if ‘there will be an outbreak of one of these coronaviruses but rather when and how prepared we’ll be to address it.”
SARS first jumped from animals to humans in 2002-2003 and caused a worldwide outbreak, resulting in 8,000 cases, including one case in Chapel Hill. With nearly 800 deaths during that outbreak, SARS-CoV presents much like flu symptoms but then can accelerate, compromise breathing and bring on a deadly form of pneumonia. The outbreak was controlled through public health interventions and the original virus was thought to have been extinct since 2004.
Baric and his team demonstrated that the newly-identified SARS-like virus, labeled SHC014-CoV and found in the Chinese horseshoe bats, can jump between bats and humans by showing that the virus can latch onto and use the same human and bat receptor for entry. The virus also replicates as well as SARS-CoV in primary human lung cells, the preferred target for infection.
“This virus is highly pathogenic and treatments developed against the original SARS virus in 2002 and the ZMapp drugs used to fight Ebola fail to neutralize and control this particular virus,” said Baric. “So building resources, rather than limiting them, to both examine animal populations for new threats and develop therapeutics is key for limiting future outbreaks.”
Read more: New SARS-like virus can jump directly from bats to humans, no treatment available
The Latest on: SARS-like virus
[google_news title=”” keyword=”SARS-like virus” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: SARS-like virus
- Move Over, Covid—There's Another Virus on the Riseon May 17, 2024 at 10:41 am
Yes, other viruses like a parvovirus, a roseola virus, or an enterovirus can cause fever and rash. If your child only has a rash without fever, that rash could be due to an allergic reaction. But the ...
- Elevated carbon dioxide lets Sars-CoV-2 live far longer in dropletson May 17, 2024 at 1:30 am
What’s more, the researchers say that they have discovered that the aerosolised Sars-CoV-2 decays over a complex three-stage process rather than a half-life. This is a new finding, which should ...
- Genetic analyses of the bird flu virus unveil its evolution and potentialon May 16, 2024 at 8:00 am
A flurry of reports about the genetics of the bird flu currently infecting U.S. cattle are offering insight into how the virus has and continues to spread. Since it first emerged in late 2020, this ...
- Study finds COVID-19 virus can penetrate the blood-retinal barrieron May 15, 2024 at 7:44 pm
The blood-retinal barrier safeguards our vision by blocking microbial pathogens from reaching the retina and causing inflammation that could lead to vision loss. However, researchers at the University ...
- COVID-19 Virus Penetrates Blood–Retinal Barrier and Could Damage Visionon May 15, 2024 at 4:30 am
The blood-retinal barrier designed to protect our vision from infection can be breached by SARS-CoV-2, with potential long-term consequences in the eye.
- COVID-19 May Damage Visionon May 14, 2024 at 1:30 pm
Researchers discovered that SARS-CoV-2 can penetrate the blood-retinal barrier, potentially causing long-term eye damage.
- Study shows virus that causes COVID-19 can penetrate blood-retinal-barrier and could damage visionon May 14, 2024 at 9:25 am
The blood-retinal barrier is designed to protect our vision from infections by preventing microbial pathogens from reaching the retina where they could trigger an inflammatory response with potential ...
- Finding the chink in coronavirus's armor—experiment reveals how the main protease of SARS-CoV-2 protects itselfon May 14, 2024 at 8:44 am
The COVID-19 pandemic resulted in millions of deaths. Despite an unparalleled collaborative research effort that led to effective vaccines and therapies being produced in record-breaking time, a ...
- New viruses that could cause epidemics on the horizonon May 13, 2024 at 1:21 pm
Suddenly they appear and -- like the SARS-CoV-2 coronavirus -- can trigger major epidemics: Viruses that nobody had on their radar. They are not really new, but they have changed genetically. In ...
- Genetic analyses reveal new viruses on the horizonon May 13, 2024 at 11:52 am
Suddenly they appear, and like the SARS-CoV-2 coronavirus, can trigger major epidemics: Viruses that nobody had on their radar. They are not really new, but they have changed genetically. In ...
via Bing News